Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Blue Cross Blue Shield took steps last year to curb those costs, announcing it would no longer automatically cover the drugs, known by brand names such as Wegovy or Zepbound, when prescribed solely for weight loss
Building muscle increases your chances of maintaining weight loss if you decide to stop GLP-1 therapy
The key here is to eat something the way nature intended and not how large-scale factories want it
The market size reached USD 534.1 million in 2025, growing from USD 374.9 million in 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management but increasingly prescribed for weight management
US$ 21.72
US$ 24.00
US$ 27.55
US$ 20.84
US$ 23.22
US$ 29.47
US$ 20.29
US$ 26.03
